David L. Grange - May 9, 2022 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Director
Signature
/s/ Jessica Morris, Attorney-in-Fact
Stock symbol
TNXP
Transactions as of
May 9, 2022
Transactions value $
$0
Form type
4
Date filed
5/11/2022, 05:42 PM
Previous filing
May 12, 2021
Next filing
May 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNXP Stock Option Award $0 +2.13M $0.00 2.13M May 9, 2022 Common Stock 2.13M $0.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.